Name: D-Nome Financials 2026 – Revenue, P&L & Cash Flow
Creator: Inc42 Datalabs

Acquisition highlights of D-Nome and a snapshot of its key metrics.

Founded in 2021, D-Nome operates in the health technology sector and provides a SaaS product for diagnostic data management and analysis. Initially focused on streamlining diagnostic workflows for medical labs, the company has since evolved to include advanced data analytics capabilities. D-Nome enhanced its platform to integrate AI-driven insights for improved patient care and diagnostics. The company has expanded its offerings to cater to various healthcare providers beyond traditional diagnostic labs. Competing with companies such as Eyestem and 4baseCare.

Divya Sriram

Sujoy Deb

Funding highlights of D-Nome and a snapshot of its key metrics.

Ankur Capital

Campus Fund

Impact India Investment Partners

8X Ventures

Seeders

Entrepreneur First

Rebalance

Investment highlights of D-Nome and a snapshot of its key metrics.

D-Nome reported ₹1.2 Cr revenue in FY24 with a profit of ₹0.3 Cr. Explore P&L, balance sheet and cash flow on Inc42 Datalabs.

D-Nome Financials 2026 – Revenue, P&L & Cash Flow

D-Nome

A snapshot of highlights, scale, and metrics

A Health Tech Funded Company Based Out Of Hyderabad

Decoding financial health metrics of D-Nome

D-Nome - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

D-Nome: Financial Breakdown

Disclaimer